NAGE ChromaDex Corp. Expected net earnings per share growth this year
Chromadex Corp controls the NAD+ market through exclusive patents on Niagen, ensuring stable demand. The YoY net income per share trend confirms the success of developing innovative anti-aging supplements, with the current level standing at -71.70. Simultaneously, the company is implementing sustainable supply chain controls and packaging recycling, adhering to modern industry safety standards.
Analytical breakdowns and data insights for company ChromaDex Corp (NAGE)
- stock quotes and analyst forecast:
- market capitalization data:
- shareholders' equity book value data:
- debt and solvency information:
Total Debt to Capital Chromadex Corp|NAGE - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio ChromaDex Corp.|NAGE - Company Aggregate Debts|Debts to Book Value ChromaDex Corp.|NAGE - Company Long-Term Debt|Company Short-Term Indebtedness ChromaDex|Intermediate Liquidity Ratio niagenbioscience.com
- earnings and valuation multiples indicators:
NAGE - Company Net Income|Company Profit Forecast Chromadex Corp|NAGE - P/E Multiple|Projected Price to Earnings ChromaDex Corporation|NAGE - PEG Multiple|Business Value to Operating Income Before Depreciation ChromaDex Corp.|NAGE - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year ChromaDex|NAGE - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months niagenbioscience.com|NAGE - Earnings per share growth in current year|Expected earnings per share growth for next year Chromadex Corp
- revenue and sales proceeds data:
Fundamental valuation:NAGE ChromaDex Corporation
To objectively assess the fundamental quality of Chromadex Corp (NAGE), investors must track the year-over-year dynamics of earnings per share. By analyzing the annual EPS change, one can promptly identify net income growth rates, which for this company confirms the effectiveness of patent protection for unique biocomponents and the ability to maintain pricing power in the global market.
Main competitors
Earnings per share growth this year ISRG|Net earnings per share growth this year DHR|BDX (bd.com) - Net earnings per one share growth for the current year|Earnings per share growth in current year STERIS (STE)|WST (West Pharmaceutical Services Inc) - Earnings per share increase in current year|Baxter International Inc. - Net earnings per share growth this year|Earnings per share increase in current year MASI|STVN: Net earnings per share growth this year|Teleflex Incorporated (TFX) - Net earnings per share growth this year|Merit Medical Systems, Inc. (MMSI) - Earnings per share growth in current year|Net earnings per share growth this year Envista|ICUI (icumed.com) - Earnings growth in current year|Earnings per share growth rate in current year Sirona Dental Systems XRAY|Earnings per share growth in current year LeMaitre Vascular (LMAT)|AtriCure - Earnings per share growth this year|STAAR Surgical Company - Net earnings per share growth this year|Net earnings per one share growth for the current year ZIMV (ZimVie Inc)|ANGO - Earnings per share growth in current year|Expected net earnings per share growth this year Cerus Corp CERS|TKNO: Earnings growth in current year|Net earnings per share growth this year monogramorthopedics.com|STSS (sharpstechnology.com) - Earnings growth in current year|Earnings per share growth this year INFU (InfuSystem Holdings)|Earnings growth in current year UTMD|KRMD (KORU Medical Systems Inc.) - Earnings per share increase in current year|Earnings per share growth in current year Nyxoah SA NYXH|Earnings per share increase in current year MBOT|Pro-Dex Corp - Earnings growth in current year|Earnings per share growth rate in current year Zentek Ltd|ELUT: Earnings growth in current year|MLSS: Net earnings per one share growth for the current year|Net earnings per share growth this year NXGL|Earnings growth in current year Retractable Technologies|Net earnings per share growth this year HBIO (Harvard Bioscience)|FEMY (Femasys) - Earnings per share increase in current year|Earnings growth in current year MHUA (meihuamed.com)|Predictive Oncology Corp - Earnings per share growth in current year|callanjmb.com - Earnings growth in current year|Earnings per share increase in current year ATRI (atrioncorp.com)|NURO (NeuroMetrix Corp) - Net earnings per share growth this year
